Broker Notes, Comments and Analysis

Broker notes, analysis and comments

AFC Energy “outlook remains bright” says Zeus Capital

AFC Energy plc (LON:AFC) has released a year end update, which summarises the key activities in what has been a successful year for the Group. The confirmation of commercial contracts..

CentralNic Group “increasing investment to enhance long-term growth opportunities” says Zeus Capital

CentralNic Group plc (LON:CNIC) announced the closing of the Codewise acquisition and that the company continues to trade in line with market expectations. We make no changes to our forecasts,..

Purplebricks Group “is perfectly positioned to grow profitably” says Zeus Capital

Purplebricks Group plc (LON:PURP) trading update for the 6 months to 31 October, reveals: §8% rise in number of instructions to 35,387 (1H last year: 32,850) with a 20% increase for..

Oncimmune “outlook for the services business appears increasingly optimistic” says Zeus Capital

Oncimmune Holdings plc (LON:ONC) FY 2020 was the first full year of delivery under Oncimmune’s three-year plan of operational, technical and commercial targets for products and services, accomplishing major milestones..

Escape Hunt “well positioned to take market share in the emerging experiential entertainment sector” says Zeus Capital

Escape Hunt plc (LON:ESC) announced the acquisition of its Middle East master franchise partner, Escape Hunt Entertainment LLC (“EHE”). The operation offers high potential returns at modest cost and risk..

Tatton Asset Management “trading well and remains financially strong” says Zeus Capital

Tatton Asset Management plc (LON:TAM) trading update reveals 17% rise in assets under management (AuM), double digit revenue growth, and an increasing operating margin as the business scales. The outlook..

Serinus Energy Analyst Q&A: Drilling should add catalysts and potentially new discovered resources

Serinus Energy plc (LON:SENX) announced last week that it has received a further 12-month extension to its key Satu Mare licence. DirectorsTalk asked Daniel Slater, Analyst at Arden Partners for..

OnTheMarket “expecting 2H revenue to double to £1m” says Zeus Capital

OnTheMarket plc (LON:OTMP) interims to 31 July 2020 provide colour to recent announcements, which reported YoY growth and cash generation. Key points are: 28% rise in revenue to £10.2m (1H19/20:..

City of London Investment Group: Boost from positive markets and deal completion

City of London Investment Group plc (LON:CLIG) has announced a trading statement covering its first quarter FUM and financial performance. With the Karpus merger taking place on 1 October, all..

Tissue Regenix Group: Funded through to profitability

Tissue Regenix Group plc (LON:TRX) is focused on the development and commercialisation of two proprietary decellularisation technologies for repair of soft tissue (dCELL) and bone (BioRinse). It has a broad..

City of London Investment Group “Q1 results are consistent with our forecast” says Zeus Capital

City of London Investment Group plc (LON:CLIG) has released an impressive trading update to 30 September 2020, which includes comment on City of London Investment Management 1Q post tax profits,..

Advanced Oncotherapy: Progress towards commissioning of first LIGHT

Advanced Oncotherapy plc (LON:AVO) goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology developed originally at the world-renowned CERN. Over the past two..

Oncimmune “COVID-19 NavigAID panel participation enhances the investment case” says Zeus Capital

The award of funding to Oncimmune Holdings plc (LON:ONC) by the ‘UK Research and Innovation Ideas to Address COVID-19’ project, leverages its proprietary ImmunoINSIGHTS technology to help in predicting disease..

Sumo Group “profits well above expectations” says Zeus Capital

Sumo Group plc (LON:SUMO) H1 results were ahead of our estimates. However, excluding select factors, profits were well above our expectations. Sumo’s strong underlying results positions it to outperform current..

Diurnal Group: And then there were three

Diurnal Group plc (LON:DNL) is a commercial-stage specialty pharmaceutical company focused on diseases of the endocrine system. Its products are targeting rare conditions where medical need is currently unmet, with..

Chamberlin: Trading update most encouraging

Chamberlin plc (LON:CMH) recent trading update was most encouraging, considering these challenging times. The company continues to take appropriate operational strategic actions. The group has been financially de-risked, but financial..

Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital

News has been positive in the past few months. Surface Transforms plc (LON:SCE) announced a ground-breaking £27.5m contract award with a new OEM customer in mid-September. Trading has been more..

ICG Enterprise Trust Defensive growth (Analyst Interview)

ICG Enterprise Trust plc (LON:ICGT) is the topic of conversation when Mark Thomas talks to DirectorsTalk. Mark explains why he called his report Defensive growth: explaining downside resilience, why PE..

GYG “order book is at record levels providing more forward visibility than ever before” says Zeus Capital

Following a number of recent contracts wins GYG plc (LON:GYG) order book now stands at record levels, which we believe should give investors confidence in current forecasts. We leave our..

Shield Therapeutics: Optimism over US deal

Shield Therapeutics plc (LON:STX) is a commercial-stage company delivering specialty products that address patients’ unmet medical needs, with an initial focus on treating iron deficiency (ID). Feraccru/Accrufer has been approved..

Search

Funds

Broker Notes, Comments and Analysis

Search

Funds

Broker Notes, Comments and Analysis

FTSE 100

Funds